Literature DB >> 11101219

Production of stable isotope enriched antimicrobial peptides in Escherichia coli: an application to the production of a 15N-enriched fragment of lactoferrin.

A Majerle1, J Kidric, R Jerala.   

Abstract

A method is described for the production of recombinant isotopically enriched peptides in E. coli. Peptides are produced in high yield as fusion proteins with ketosteroid isomerase which form insoluble inclusion bodies. This insoluble form allows easy purification, stabilizes the peptide against degradation and prevents bactericidal activity of the peptide. Cyanogen bromide cleavage released peptide which was conjugated with alkylamines to form lipopeptide. An important advantage of this system is that it allows production of peptides that are toxic to bacteria, which we have demonstrated on a dodecapeptide based on residues 21-31 of human bactericidal protein lactoferrin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11101219     DOI: 10.1023/a:1008362401928

Source DB:  PubMed          Journal:  J Biomol NMR        ISSN: 0925-2738            Impact factor:   2.835


  25 in total

1.  The rapid generation of mutation data matrices from protein sequences.

Authors:  D T Jones; W R Taylor; J M Thornton
Journal:  Comput Appl Biosci       Date:  1992-06

2.  Expressed protein ligation, a novel method for studying protein-protein interactions in transcription.

Authors:  K Severinov; T W Muir
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

3.  Structure-function relationship of antibacterial synthetic peptides homologous to a helical surface region on human lactoferrin against Escherichia coli serotype O111.

Authors:  D S Chapple; D J Mason; C L Joannou; E W Odell; V Gant; R W Evans
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Gene fragment polymerization gives increased yields of recombinant human proinsulin C-peptide.

Authors:  P Jonasson; P A Nygren; B L Johansson; J Wahren; M Uhlén; S Ståhl
Journal:  Gene       Date:  1998-04-14       Impact factor: 3.688

5.  Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli.

Authors:  L H Vorland; H Ulvatne; O Rekdal; J S Svendsen
Journal:  Scand J Infect Dis       Date:  1999

Review 6.  The two-dimensional transferred nuclear Overhauser effect: theory and practice.

Authors:  A P Campbell; B D Sykes
Journal:  Annu Rev Biophys Biomol Struct       Date:  1993

7.  A transmembrane helix dimer: structure and implications.

Authors:  K R MacKenzie; J H Prestegard; D M Engelman
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

8.  A new general method for the biosynthesis of stable isotope-enriched peptides using a decahistidine-tagged ubiquitin fusion system: an application to the production of mastoparan-X uniformly enriched with 15N and 15N/13C.

Authors:  T Kohno; H Kusunoki; K Sato; K Wakamatsu
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

9.  Expressed protein ligation: a general method for protein engineering.

Authors:  T W Muir; D Sondhi; P A Cole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

10.  Antibacterial activity of peptides homologous to a loop region in human lactoferrin.

Authors:  E W Odell; R Sarra; M Foxworthy; D S Chapple; R W Evans
Journal:  FEBS Lett       Date:  1996-03-11       Impact factor: 4.124

View more
  11 in total

1.  High-yield expression of isotopically labeled peptides for use in NMR studies.

Authors:  Darrin A Lindhout; Angela Thiessen; Dean Schieve; Brian D Sykes
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

2.  Efficient expression of isotopically labeled peptides for high resolution NMR studies: application to the Cdc42/Rac binding domains of virulent kinases in Candida albicans.

Authors:  Michael J Osborne; Zhengding Su; Vasanth Sridaran; Feng Ni
Journal:  J Biomol NMR       Date:  2003-08       Impact factor: 2.835

3.  An expression and purification system for the biosynthesis of adenosine receptor peptides for biophysical and structural characterization.

Authors:  Zachary T Britton; Elizabeth I Hanle; Anne S Robinson
Journal:  Protein Expr Purif       Date:  2012-06-19       Impact factor: 1.650

4.  Bcl-XL as a fusion protein for the high-level expression of membrane-associated proteins.

Authors:  Khang Thai; Jungyuen Choi; Carla M Franzin; Francesca M Marassi
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

5.  Combination of antimicrobial and endotoxin-neutralizing activities of novel oleoylamines.

Authors:  Mateja Zorko; Andreja Majerle; David Sarlah; Mateja Mancek Keber; Barbara Mohar; Roman Jerala
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  A rapid method to attain isotope labeled small soluble peptides for NMR studies.

Authors:  Bernd W Koenig; Marco Rogowski; John M Louis
Journal:  J Biomol NMR       Date:  2003-07       Impact factor: 2.835

7.  Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli.

Authors:  Julie K Klint; Sebastian Senff; Natalie J Saez; Radha Seshadri; Ho Yee Lau; Niraj S Bende; Eivind A B Undheim; Lachlan D Rash; Mehdi Mobli; Glenn F King
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

8.  Construction of a series of vectors for high throughput cloning and expression screening of membrane proteins from Mycobacterium tuberculosis.

Authors:  Huajun Qin; Jian Hu; Yuanzhi Hua; Shridhar V Challa; Timothy A Cross; Fei P Gao
Journal:  BMC Biotechnol       Date:  2008-05-16       Impact factor: 2.563

9.  Prokaryotic expression and mechanism of action of α-helical antimicrobial peptide A20L using fusion tags.

Authors:  Tonghui Yi; Shiyu Sun; Yibing Huang; Yuxin Chen
Journal:  BMC Biotechnol       Date:  2015-08-05       Impact factor: 2.563

10.  Recombinant Expression and Characterization of α-Conotoxin LvIA in Escherichia coli.

Authors:  Xiaopeng Zhu; Jianpeng Bi; Jinpeng Yu; Xiaodan Li; Yaning Zhang; Dongting Zhangsun; Sulan Luo
Journal:  Mar Drugs       Date:  2016-01-05       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.